| 股號 / 名稱 | 總負債 | 淨值 |
| ABT 美國雅培 | 33,227,000,000.0 | 50,954,000,000.0 |
| MDT 美敦力 | 42,693,000,000.0 | 48,653,000,000.0 |
| NVO 諾和諾德 | 53,865,109,440.0 | 26,728,038,720.0 |
| BSX Boston Scientific Corp | 19,313,000,000.0 | 23,394,000,000.0 |
| SYK 史賽克 | 25,272,000,000.0 | 21,785,000,000.0 |
| ZBH Zimmer Biomet Holdings Inc | 10,731,500,000.0 | 12,756,500,000.0 |
| PHG Koninklijke Philips NV | 18,527,307,460.0 | 12,383,616,160.0 |
| BIO Bio Rad Laboratories Inc | 2,959,600,000.0 | 6,736,800,000.0 |
| RMD 瑞思邁 | 2,187,088,000.0 | 6,121,264,000.0 |
| NVST Envista Holdings Corp | 2,554,300,000.0 | 3,088,200,000.0 |
| ICUI ICU Medical Inc | 1,975,646,000.0 | 2,127,250,000.0 |
| NEOG Neogen Corp | 1,255,465,000.0 | 2,104,488,000.0 |
| QDEL QuidelOrtho Corp | 3,638,700,000.0 | 2,036,400,000.0 |
| EYE National Vision Holdings Inc | 1,099,711,000.0 | 858,761,000.0 |
| INMD Inmode Ltd | 81,220,000.0 | 653,385,000.0 |
| TGTX TG Therapeutics Inc | 417,806,000.0 | 607,218,000.0 |
| ATRC AtriCure Inc | 158,935,000.0 | 476,507,000.0 |
| WRBY Warby Parker Inc | 337,296,000.0 | 369,625,000.0 |
| BLFS BioLife Solutions Inc | 38,342,000.0 | 353,739,000.0 |
| QTRX Quanterix Corp | 129,606,000.0 | 314,534,000.0 |
| PAHC Phibro Animal Health Corp | 1,073,843,000.0 | 311,681,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 603,748,000.0 | 245,443,000.0 |
| ORMP Oramed Pharmaceuticals Inc | 17,211,000.0 | 203,282,000.0 |
| VALN Valneva SE | 349,435,792.16 | 176,596,797.66 |
| VMD Viemed Healthcare Inc | 68,752,000.0 | 133,608,000.0 |
| UTMD Utah Medical Products Inc | 3,723,000.0 | 118,252,000.0 |
| CAPR Capricor Therapeutics Inc | 42,570,950.0 | 83,867,260.0 |
| MGNX MacroGenics Inc | 203,762,000.0 | 67,001,000.0 |
| FLGC Flora Growth Corp | 9,096,000.0 | 64,920,000.0 |
| CERS Cerus Corp | 153,722,000.0 | 61,463,000.0 |
| INFU InfuSystem Holdings Inc | 43,410,000.0 | 55,471,000.0 |
| ZVIA Zevia PBC | 8,759,000.0 | 51,250,000.0 |
| RMTI Rockwell Medical Inc | 20,466,000.0 | 37,020,000.0 |
| ICCC ImmuCell Corp | 15,929,280.0 | 29,800,840.0 |
| VERU Veru Inc | 11,503,050.0 | 18,332,670.0 |
| XGN Exagen Inc | 44,685,000.0 | 18,138,000.0 |
| MYO Myomo Inc | 19,451,850.0 | 14,625,580.0 |
| SNES Senestech Inc | 3,276,000.0 | 11,348,000.0 |
| UG United-Guardian Inc | 1,597,910.0 | 10,582,440.0 |
| PHGE Biomx Inc | 15,682,000.0 | 10,486,000.0 |
| NEPH Nephros Inc | 3,241,000.0 | 10,006,000.0 |
| CLRB Cellectar Biosciences Inc | 5,248,260.0 | 9,379,330.0 |
| CTSO Cytosorbents Corp | 36,730,000.0 | 9,020,000.0 |
| APYX Apyx Medical Inc | 51,517,000.0 | 5,848,000.0 |
| IMCC IM Cannabis Corp | 29,011,181.85 | 2,848,009.95 |
| GCTK GlucoTrack Inc | 5,539,000.0 | 2,751,000.0 |
| EOLS Evolus Inc | 247,757,000.0 | -28,760,000.0 |
| OMER Omeros Corp | 406,184,000.0 | -220,478,000.0 |
| BRBR Bellring Brands Inc | 1,394,900,000.0 | -453,900,000.0 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例